{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:03:49Z","timestamp":1772780629821,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.yebeh.2012.08.008","type":"journal-article","created":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T04:15:20Z","timestamp":1347855320000},"page":"464-467","source":"Crossref","is-referenced-by-count":6,"title":["The association of anti-glutamic acid decarboxylase antibodies with different neurological findings in childhood"],"prefix":"10.1016","volume":"25","author":[{"given":"Mehpare","family":"Ozkan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fe","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"\u00c7enesiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilg\u00fcn Erkek","family":"Atay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2012.08.008_bb0005","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0010","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1167.2009.02325.x","article-title":"Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy","volume":"51","author":"Liimatainen","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0015","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1469-8749.2008.03217.x","article-title":"Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency","volume":"51","author":"Akman","year":"2009","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0025","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archneurol.2011.177","article-title":"Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition?","volume":"68","author":"Korff","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0030","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1542\/peds.109.3.e50","article-title":"Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies","volume":"109","author":"Olson","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NRL.0b013e31813e34a5","article-title":"Limbic encephalitis and variants: classification, diagnosis and treatment","volume":"13","author":"Tuzun","year":"2007","journal-title":"Neurologist"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0040","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","article-title":"GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders","volume":"76","author":"Boronat","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2009.09.004","article-title":"Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality?","volume":"287","author":"Blanc","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2008.05.015","article-title":"Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies","volume":"199","author":"Mata","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/jnnp.70.3.386","article-title":"Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia","volume":"70","author":"Takenoshita","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0060","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.21123","article-title":"Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases","volume":"61","author":"Manto","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy","volume":"55","author":"Peltola","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0070","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1468-1331.2011.03609.x","article-title":"Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies","volume":"19","author":"Falip","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.04.010","article-title":"Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients","volume":"211","author":"Errichiello","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ana.21011","article-title":"Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes","volume":"63","author":"Striano","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.yebeh.2010.10.006","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with epilepsy: what is their clinical relevance?","volume":"20","author":"Striano","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-510X(00)00272-0","article-title":"Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase","volume":"175","author":"Mitoma","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0100","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/clinchem\/45.12.2269","article-title":"Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: influence of comorbidity, age, and sex on specificity and threshold values","volume":"45","author":"Batstra","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.20727","article-title":"An association between type 1 diabetes and idiopathic generalized epilepsy","volume":"59","author":"McCorry","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2012.08.008_bb0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1468-1331.2004.00933.x","article-title":"Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies","volume":"12","author":"Vianello","year":"2005","journal-title":"Eur J Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505012005264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505012005264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T21:46:20Z","timestamp":1594676780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505012005264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1525505012005264"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2012.08.008","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}